Circulating Proteome and Progression of Type 2 Diabetes

Wanglong Gou,Liang Yue,Xin-Yi Tang,Yan-Yan Wu,Xue Cai,Menglei Shuai,Zelei Miao,Yuanqing Fu,Hao Chen,Zengliang Jiang,Jiali Wang,Yunyi Tian,Congmei Xiao,Nan Xiang,Zhen Wu,Yu-Ming Chen,Tiannan Guo,Ju-Sheng Zheng
DOI: https://doi.org/10.1210/clinem/dgac098
2022-05-17
Abstract:Context: Circulating proteomes may provide intervention targets for type 2 diabetes (T2D). Objective: We aimed to identify proteomic biomarkers associated with incident T2D and assess its joint effect with dietary or lifestyle factors on the T2D risk. Methods: We established 2 nested case-control studies for incident T2D: discovery cohort (median 6.5 years of follow-up, 285 case-control pairs) and validation cohort (median 2.8 years of follow-up, 38 case-control pairs). We integrated untargeted mass spectrometry-based proteomics and interpretable machine learning to identify T2D-related proteomic biomarkers. We constructed a protein risk score (PRS) with the identified proteomic biomarkers and used a generalized estimating equation to evaluate PRS-T2D relationship with repeated profiled proteome. We evaluated association of PRS with trajectory of glycemic traits in another non-T2D cohort (n = 376). Multiplicative interactions of dietary or lifestyle factors with PRS were evaluated using logistic regression. Results: Seven proteins (SHBG, CAND1, APOF, SELL, MIA3, CFH, IGHV1-2) were retained as the proteomic biomarkers for incident T2D. PRS (per SD change) was positively associated with incident T2D across 2 cohorts, with an odds ratio 1.29 (95% CI, 1.08-1.54) and 1.84 (1.19-2.84), respectively. Participants with a higher PRS had a higher probability showing unfavored glycemic trait trajectory in the non-T2D cohort. Red meat intake and PRS showed a multiplicative interaction on T2D risk in the discovery (P = 0.003) and validation cohort (P = 0.017). Conclusion: This study identified proteomic biomarkers for incident T2D among the Chinese populations. The higher intake of red meat may synergistically interact with the proteomic biomarkers to exaggerate the T2D risk.
What problem does this paper attempt to address?